Merck
Rahway, New Jersey, United States · Biotechnology, Healthcare, Health Care
For over 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and par
Key facts
- Headquarters
- Rahway, New Jersey, United States
- Employees
- 75,000
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (MRK)
- Website
- merck.com
Recent activity at Merck
- : SEC 8-K (5.02): The filing pertains to the departure and election of directors at Merck & Co., Inc. Paul J. Diaz has been elected to the Company's Board of Directors, with his appointment effective November 1, 2026. He will also serve on the Audit Committee and the Research Committee, receiving compensation as per the Company’s standard non-employee director compensation practices. This appointment was formally announced in a press release issued on October 13, 2026, reflecting the Company’s ongoing effort to strengthen its leadership within the governance structure.
- : Merck enters $2.13 billion agreement with SciBrunch to license preclinical KRAS inhibitor SPR2015.
- : Merck completes acquisition of Harpoon Therapeutics
- : Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine; BARDA to Provide Merck With Funding to Expand Merck’s Manufacturing Capacity for COVID-19 Vaccines and Medicines
- : Merck acquires Prometheus for $10.8 billion
- : Merck acquires Prometheus Biosciences for $10.8B
- : Merck Appoints Clara Sattler de Sousa e Brito as Head of Discovery Solutions and Robert Machinek as Head of Strategy & Business Development
- : SEC 8-K (8.01): On May 22, 2026, Merck & Co., Inc. completed an underwritten public offering of various series of notes, totaling $5.5 billion. This includes Floating Rate Notes due 2028, 4.300% Notes due 2028, 4.650% Notes due 2031, 4.950% Notes due 2033, 5.200% Notes due 2036, 5.750% Notes due 2046, and 5.850% Notes due 2056. The offering was conducted under the Company's Registration Statement on Form S-3ASR. The notes are secured by an indenture with U.S. Bank Trust National Association. This financing will provide Merck with capital, potentially enhancing liquidity for strategic initiatives.
- : SEC 8-K (8.01): On May 22, 2026, Merck & Co., Inc. closed an underwritten public offering of several series of notes, including a 1.875% Notes due 2026, 3.250% Notes due 2032, 2.500% Notes due 2034, 1.375% Notes due 2036, 3.500% Notes due 2037, 3.700% Notes due 2044, and 3.750% Notes due 2054. The offering was executed through various securities exchange listings including the New York Stock Exchange. The exact financial amounts for the proceeds were not disclosed in the filing, but this transaction is expected to enhance Merck's capital structure and provide liquidity for strategic initiatives. Closing date for the offering was noted as May 22, 2026, which directly aligns with this filing indicating the timely nature of the reported event.
- : Merck and Google Cloud Form $1 Billion Partnership to Drive AI Transformation in Pharma.
Merck funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2020 | Venture | $50.0M |
Leadership
- Pranav Joshi, Business Insights & Development, Experience Design, CTO Org
- Keith Lillico, Assocate Director Global Learning Development (Enterprise Learning Creation Lead)
- Ajay Wakhloo, Executive Officer, Director
- Marc Litzenberg, Executive Officer, Director
- Baruch Lieber, Executive Officer, Director
- James Laur, Director
- Joseph Papa, Director
- Adam Stone, Director
- Shierley Widjaja, Director
- Mark McKenna, Executive Officer, Director
Verified email and direct lines for Merck’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Merck in the news
- Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business - Fierce Pharma (Nov 03, 2026)
- Merck KGaA to Divest CDMO Business to Lonza - Oncodaily (Nov 04, 2026)
- The new R&D and manufacturing facilities powering our US growth - Merck | Home (Oct 14, 2026)
- Addressing the global shortage of TICE BCG - Merck | Home (Sep 21, 2026)
- Merck Initiates Phase 3 Study Evaluating Ohtuvayre® (ensifentrine) for the Prevention of COPD Exacerbations in Adult Patients Receiving Standard of Care With a History of Exacerbations - Business Wire (Nov 03, 2026)
- FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) - Merck | Home (Apr 21, 2026)
- Our Q4 and full-year 2025 financial results - Merck (Feb 03, 2026)
- 5 ways we’re transforming artificial intelligence into impact - Merck | Home (Jan 09, 2026)
Companies similar to Merck
- AbbVie Inc. · Biotechnology, Healthcare, Health Care, Manufacturing
- Edwards Lifesciences · Biotechnology, Healthcare, Health Care, Manufacturing
- Integer Holdings Corporation · Biotechnology, Healthcare, Health Care, Manufacturing
- Medtronic plc · Biotechnology, Health Care, Manufacturing
- Philip Morris International · Biotechnology, Health Care, Manufacturing
About Merck: questions and answers
What does Merck do?
For over 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and par
Where is Merck headquartered?
Merck is headquartered in Rahway, New Jersey, United States.
How many employees does Merck have?
Merck has about 75,000 employees.
Has Merck raised funding?
Yes. Fundz has recorded 1 funding event for Merck. The most recent, $50.0M, was in Nov 2020.
What is the latest news on Merck?
On Oct 13, 2026, SEC 8-K (5.02): The filing pertains to the departure and election of directors at Merck & Co., Inc. Paul J. Diaz has been elected to the Company's Board of Directors, with his appointment effective November 1, 2026. He will also serve on the Audit Committee and the Research Committee, receiving comp
Is Merck a public company?
Yes. Merck is publicly traded under the ticker MRK.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy